Literature DB >> 28599056

Retrospective study of the prognostic significance of neutrophil-to-lymphocyte ratio for postsurgical outcomes of patients with endometrial carcinoma.

Ling Ding1, Yi Ding1, Xiao-Hua Mao1, Jian-Fei Zhao1, Huai-Jun Zhou1.   

Abstract

OBJECTIVE: To evaluate the significance of postoperative inflammatory system response markers in predicting the prognosis of patients with endometrial cancer undergoing surgery.
METHODS: The present retrospective study included patients who underwent surgical treatment for pathology-confirmed endometrial cancer between January 1, 2007, and June 30, 2013, at the Affiliated Drum Tower Hospital, Nanjing University Medical School, Nanjing, China. Potential prognostic factors were investigated by Cox proportional hazards analysis and survival rates were compared using Kaplan-Meier analyses.
RESULTS: There were 185 patients with surgically treated endometrial cancer included. Multivariate analyses demonstrated that a preoperative neutrophil-to-lymphocyte ratio (NLR) above 1.81 (P=0.010) and a postoperative NLR above 7.54 (P=0.008) were both independently associated with lower disease free survival. Elevated preoperative and postoperative NLRs were associated with higher tumor stage (P=0.021 and P=0.009, respectively), and only elevated preoperative NLR was associated with lymph node involvement (P=0.023).
CONCLUSION: Preoperative and postoperative NLRs were independently associated with inflammatory system response markers and could be combined to evaluate the prognosis of patients with endometrial cancer following surgery.
© 2017 International Federation of Gynecology and Obstetrics.

Entities:  

Keywords:  Endometrial cancer; Neutrophil-to-lymphocyte ratio; Prognosis; Systemic inflammatory response

Mesh:

Substances:

Year:  2017        PMID: 28599056     DOI: 10.1002/ijgo.12230

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  8 in total

1.  Injection rate of contrast medium affects diagnostic ability of dynamic contrast-enhanced magnetic resonance imaging for endometrial carcinoma: a prospective cohort study.

Authors:  Donghui Xu; Aiping Jin; Yongqian Ge; Yanmei Zhang
Journal:  Gland Surg       Date:  2021-08

2.  Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta-analysis.

Authors:  Jiali Leng; Fei Wu; Lihui Zhang
Journal:  Front Oncol       Date:  2022-05-16       Impact factor: 5.738

3.  Prognostic value of lymphocyte-to-monocyte ratio among Asian lung cancer patients: a systematic review and meta-analysis.

Authors:  Wen Li; Guangzhi Ma; Qiang Wu; Yunfu Deng; Ya Liu; Jing Wang
Journal:  Oncotarget       Date:  2017-08-28

4.  Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: a superior prognostic factor of endometrial cancer.

Authors:  Rong Cong; Fanfei Kong; Jian Ma; Qing Li; Qijun Wu; Xiaoxin Ma
Journal:  BMC Cancer       Date:  2020-05-24       Impact factor: 4.430

5.  Prognostic values of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in endometrial cancer: a systematic review and meta-analysis.

Authors:  Liwei Ni; Jialong Tao; Jianhao Xu; Xuya Yuan; Yuming Long; Na Yu; Runhong Wu; Yusong Zhang
Journal:  Arch Gynecol Obstet       Date:  2019-11-25       Impact factor: 2.344

6.  Pre-treatment inflammatory parameters predict survival from endometrial cancer: A prospective database analysis.

Authors:  Kelechi Njoku; Neal C Ramchander; Y Louise Wan; Chloe E Barr; Emma J Crosbie
Journal:  Gynecol Oncol       Date:  2021-11-19       Impact factor: 5.482

7.  Predictive Value of Hematological Inflammatory Markers in Endometrial Neoplasia

Authors:  Besim Haluk Bacanakgil; Isik Kaban; Fehmi Unal; Rabia Guven; Ece Sahin; Sezgi Gullu Yildirim
Journal:  Asian Pac J Cancer Prev       Date:  2018-06-25

Review 8.  C-Reactive Protein to Albumin Ratio in Colorectal Cancer: A Meta-Analysis of Prognostic Value.

Authors:  Qiang-Ping Zhou; Xiu-Jiang Li
Journal:  Dose Response       Date:  2019-11-20       Impact factor: 2.658

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.